Lv3
278 积分 2024-06-26 加入
Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children
1天前
已完结
TP53 deletion as an MRD‐dependent risk factor in childhood B‐ALL: A post hoc analysis from a prospective cohort
1个月前
已完结
TP53 Mutations are Associated with CD19 Negative Relapse and Inferior Outcomes after Blinatumomab in Adults with ALL
1个月前
已完结
TP53 Mutations are Associated with CD19 Negative Relapse and Inferior Outcomes after Blinatumomab in Adults with ALL
1个月前
已关闭
Circulating Tumor DNA as Measurable Residual Disease in Aggressive B-Cell Lymphoma
1个月前
已完结
Genetic subtypes of B-cell acute lymphoblastic leukemia in adults
1个月前
已关闭
The genomic basis of childhood T-lineage acute lymphoblastic leukaemia
1个月前
已完结
Clinical use of measurable residual disease in adult ALL: recommendations from a panel of U.S. experts
2个月前
已完结
Clinical use of measurable residual disease in adult ALL: recommendations from a panel of U.S. experts
2个月前
已关闭
Circulating Tumor DNA as Measurable Residual Disease in Aggressive B-Cell Lymphoma
2个月前
已完结
皖公网安备34019202002308
